Open AccessReduced angiopoietin-2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndrome
Author(s) -
Luxmipratha Rajendiran,
Hanumanthappa Nandeesha,
Thyagaraju Chitra
Publication year - 2021
Publication title -
journal of human reproductive sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.484
H-Index - 31
eISSN - 0974-1208
pISSN - 1998-4766
DOI - 10.4103/jhrs.jhrs_179_20
Subject(s) - polycystic ovary , angiopoietin 2 , infertility , insulin resistance , medicine , body mass index , biomarker , gynecology , endocrinology , pregnancy , obesity , chemistry , biology , biochemistry , vascular endothelial growth factor , vegf receptors , genetics
Even though angiopoeitin-2 and interleukin (IL)-23 are known to be altered in polycystic ovary syndrome (PCOS), their association with clomiphene citrate (CC) resistance has not been studied.